Financial
FY2025 revenue €1.21bn (+5.0%).
Revenue +5% (organic +5%). Profit figures not yet captured.
HQ Germany · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2025 revenue €1.21bn (+5.0%).
Revenue +5% (organic +5%). Profit figures not yet captured.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | €1.2bn | +5.0% | — | — | CompuGroup Medical |
Products not yet catalogued.
FY2025 revenue €1.21bn (+5.0%).
Revenue +5% (organic +5%). Profit figures not yet captured.
Jun 2025: CompuGroup Medical left the stock exchange after a delisting offer by investor CVC, with the founding Gotthardt family keeping a majority; in Jul 2025 the head of its German ambulatory division departed.
Jul 2025: a German security blog reported, from an anonymous source, alleged weaknesses in CGM's Z1 dental practice software, including shared default database credentials and unencrypted backups; the blog said CGM has since released an update. NHS DSPT status not yet checked.
No recalls, safety notices or clinical safety incidents involving CompuGroup Medical found in HSH's search of the last 24 months.
Jul 2025: CompuGroup Medical won a Bundeswehr tender to supply outpatient doctor and dentist information systems for up to seven years, reported at a mid-double-digit million euro value.
No competitors linked yet.